News

Repurposed diabetes drug can reduce pain for those with knee arthritis and overweight or obesity, clinical trial shows
A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying ...
Medscape1d
One Patient, Three Different CGMs, Three Glucose Profiles
In a head-to-head study, three continuous glucose monitoring systems show different measurements in the same person, which may affect therapeutic decision-making.
FDA stops sale of generic versions of Ozempic and Wegovy: What it means for patients
Receiving a generic version of Ozempic or Wegovy from a compounding pharmacy is normally both easier to access and cheaper.
The Cardiology Advisor3d
FDA Clears Dexcom G7 15 Day for Continuous Glucose Monitoring
The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.
Axios on MSN3d
Dexcom offers NIL deals to elevate college athletes with diabetes
San Diego-based Dexcom, a leading diabetes technology company known for its wearable glucose monitors, is expanding its NIL ...
I lost 20 pounds and reversed my prediabetes in just 90 days without drugs — my exact method
Norma Lyons was 40 pounds overweight and considered tortilla a major food group when her doctor broke the news that she was ...
PharmiWeb4d
Global Glucose Sensor Market Set to Surpass USD 20,421.4 Million by 2034 Amid Rising Diabetes Concerns | FMI
Glucose Sensor MarketThe global glucose sensor market is projected to witness substantial growth, reaching a valuation of USD 20,421.4 million by 2034, according to a recent report. The market, ...
2 Cash-Producing Stocks That Stand Out and 1 to Keep Off Your Radar
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy ...